Delivery Order SPE2DB24D9223-SPE2DB24FKEDE

Award Date 9/18/24
Potential Completion Date 10/9/24
Potential Value $6.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $61,383.40 contract is for the delivery of 4564604560 - RITUXAN 500 MG/50 ML VIAL 50ML, with a completion date of June 3, 2024. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999 and running...
This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $95,618.70 contract is for the delivery of Rituxan 500 mg/50 ml vials to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $5,965.88 firm fixed-price contract is for the provision of 4567387680 ! RITUXAN 500 MG/50 ML VIAL 50ML, a specialized pharmaceutical product. The contract has an ultimate completion date of March 17, 2025. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the...
This firm-fixed-price delivery order, valued at $3,697.82, was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business in Park Ridge, Illinois. The award was made by the Defense Logistics Agency (DLA) under the DLA's SPE2DB pharmaceutical supply contract, which has a ceiling value of up to $4,999,999 through 2025. This delivery order is to provide Rituxan 500 mg/50 ml vials to support the medical supply needs of military health facilities. The contract has no set-aside...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $33,760.87 to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is for the delivery of Rituxan 500 mg/50 ml vial, a pharmaceutical product used in medical care. This delivery order is placed against DMS Pharmaceutical Group's existing indefinite delivery contract with DLA, contract #SPE2DB23D4600082013, which has a ceiling value of up to...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order worth $38,347.10 to the woman-owned small business DMS Pharmaceutical Group Inc. based in Park Ridge, Illinois. The order is for the pharmaceutical product Rituxan 500 mg/50 ml vial and has a completion date of February 28, 2023. This order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. The IDC allows the DLA to issue...
The U.S. government's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $30,691.70 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of 4565781429 RITUXAN 500 MG/50 ML VIAL 50ML to DLA's Medical Supply Chain division. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with DLA under the SPE2DB program, valued at up to $499,999,999,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $38,247.48 contract is for the delivery of RITUXAN 500 MG/50 ML VIAL 50ML to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $29,829.40, is for the delivery of 4567801943 ! RITUXAN 500 MG/50 ML VIAL 50ML. This product is a specialized pharmaceutical item used to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group Inc. holds a larger...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $9,207.51 firm fixed-price contract is for the delivery of 4564558204 RITUXAN 500 MG/50 ML VIAL 50ML, with a performance period through May 29, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery...
  • SPE2DB24D9223
    Indefinite Delivery Contract
  • SPE2DB24D9223-SPE2DB24FKEDE
    Delivery Order

This firm fixed-price delivery order was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois, by the Defense Logistics Agency (DLA) under the SPE2DB program. The $6,138.34 contract is for the delivery of the pharmaceutical product RITUXAN 500 MG/50 ML VIAL 50ML, with a completion date of October 9, 2024. DMS Pharmaceutical Group is a key supplier to the Department of Defense (DoD) and Department of Veterans Affairs (VA), providing a wide range of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the recurring medical supply needs of military health facilities and VA medical centers nationwide. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which allows the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the diverse medical requirements of DoD healthcare facilities globally.

Generated 12/18/24, 9:45 AM